A Nomogram Incorporating Inflammation and Nutrition Indexes for Predicting Outcomes in Patients with Acute Coronary Syndrome and Chronic Kidney Disease
Weicheng Ni,Zhen-ze Pan,Hao Zhou
DOI: https://doi.org/10.2147/jir.s488674
IF: 4.5
2024-11-05
Journal of Inflammation Research
Abstract:Weicheng Ni, 1 Zhen-ze Pan, 2 Hao Zhou 1 1 Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China; 2 Department of Statistics and Management, Shanghai University of Finance and Economics, Shanghai, People's Republic of China Correspondence: Hao Zhou, Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, NanBai Xiang Avenue, Ouhai District, Wenzhou, 325000, People's Republic of China, Email Background: Inflammation, immunity, and nutriture are associated with prognosis in cardiovascular disease. We aimed to devise a novel nomogram model based on inflammation and nutrition indexes that accurately predicts Major adverse renal and cardiovascular events (MARCE) in patients diagnosed with acute coronary syndrome (ACS) and coexisting chronic kidney disease (CKD). Methods: We enrolled 685 individuals with ACS and CKD between January 2013 and August 2021. All patients were randomized into the training (70%) and validation (30%) cohorts. Univariable and multivariable Cox regression analyses were used to identify independent predictors for MARCE. The performance of the nomogram model was evaluated using receiver operating characteristic (ROC) analysis, calibration curves, and decision curve analysis (DCA). The performance of the nomogram and GRACE score were compared. Results: The nomogram included six variables: age, left ventricular ejection fraction, systemic immune-inflammatory index (SII), controlling nutritional status (CONUT) score, use of beta-blockers, and use of statins. The constructed nomogram demonstrated robust predictive performance, achieving ROC ranging from 0.830 to 0.935 in the training set and 0.793 to 0.889 in the validation set, respectively. Furthermore, the calibration curves exhibited excellent agreement between the predicted probabilities and the observed outcomes, indicating the reliability of the nomogram's predictions. Finally, the DCA confirmed the clinical value of the nomogram by demonstrating its potential to improve decision-making processes in the context of managing the condition under study. Compared with the GRACE score, the nomogram was superior in terms of both discrimination and reclassification ability. Conclusion: Our novel nomogram, which incorporates the CONUT score and SII, shows promising utility for predicting MARCE in patients with ACS and CKD. The identification of patients at heightened risk through our nomogram model is paramount as it serves as a cornerstone for the implementation of targeted interventions aimed at modifiable variables. Keywords: acute coronary syndrome, chronic kidney disease, GRACE score, major adverse renal and cardiovascular events, nomogram, prediction model Chronic kidney disease (CKD) is prevalent, affecting approximately 30–40% of acute coronary syndrome (ACS). 1,2 However, major randomized clinical trials, particularly those focusing on cardiovascular disease, often underrepresent or exclude patients with CKD. 3 This underrepresentation can contribute to the underuse of evidence-based treatment for these patients, which in turn may lead to poorer outcomes despite their high-risk status. 2,4 Patients with CKD face an elevated risk of ACS, exhibit notably higher mortality rates, and are predisposed to renal function deterioration. 4–6 Managing a single-organ dysfunction without acknowledging the interconnectedness of the secondary organ within the cardiorenal axis can be misguided and potentially detrimental. The American Heart Association advocates for the utilization of major adverse renal and cardiovascular events (MARCE) as an innovative clinical endpoint for patients with cardiorenal diseases, as it offers a comprehensive definition of prognosis. 7 Identifying patients at increased risk of MARCE is an unmet need for individuals combined with ACS and CKD. The current clinical scoring systems have been used in clinical practice for over a decade. 8–10 Among them, the Global Registry of Acute Coronary Events (GRACE) score stands as an efficacious indicator, endorsed by guidelines, for predicting mortality and adverse events in patients diagnosed with ACS. 8,11 Recent studies have shown that predictive models incorporating creatinine and cardiac enzyme markers could underestimate the risk of major events for patients with kidney dysfunction. 12,13 Therefore, these models may not be widely adopted for patients combined with CKD. Moreover, models that effectively assess the prognosis of ACS and CKD are still lacking. The nomogram we developed aims to fill this gap by considering malnutrition and inflammation factors, thereby bette -Abstract Truncated-
immunology